Individual bioequivalence—a regulatory update
From MaRDI portal
Publication:4239490
DOI10.1080/10543409708835162zbMATH Open1063.62587OpenAlexW2023574125WikidataQ41369444 ScholiaQ41369444MaRDI QIDQ4239490FDOQ4239490
Authors: Meiling Chen
Publication date: 1997
Published in: Journal of Biopharmaceutical Statistics (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1080/10543409708835162
Recommendations
Cites Work
- Moment-based criteria for determining bioequivalence
- Assessment of Individual and Population Bioequivalence Using the Probability That Bioavailabilities are Similar
- The Subject-by-Formulation Interaction as a Criterion of Interchangeability of Drugs
- Extension to the use of tolerance intervals for the assessment of individual bioequivalence
Cited In (5)
- Some issues for the consideration of individual bioequivalence
- Statistical evaluation of individual bioequivalence
- `Equivalence is different' -- some comments on therapeutic equivalence
- BIOEQUIVALENCE REVIEW FOR DRUG INTERCHANGEABILITY
- Bayesian construction of an improved parametric test for probability-based individual bioequiv\-a\-lence.
This page was built for publication: Individual bioequivalence—a regulatory update
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q4239490)